Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Artifical nucleases comprising engineered cleavage half-domains

Artifical nucleases comprising engineered cleavage half-domains

US Patent 11136599 · Granted Oct 5, 2021

Estimated economic value: $23,404,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CRISPR-cas9 system and uses thereof2025
Compositions for linking DNA-binding domains and cleavage domains2024
Regulation of gene expression using engineered nucleases2023
Engineered target specific base editors2023
Engineered target specific nucleases2023
Methods and compositions for treating Huntington's Disease2023
Artificial nucleases comprising engineered cleavage half-domains2023
Artificial nucleases comprising engineered cleavage half-domains2023
DNA-binding proteins and uses thereof2023
Methods and compositions for treating hemophilia2023
Compositions for linking DNA-binding domains and cleavage domains2023
Methods and compositions for treatment of a genetic condition2022